Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats - PubMed (original) (raw)
. 2007 Oct;38(10):2795-803.
doi: 10.1161/STROKEAHA.107.483008. Epub 2007 Aug 16.
Affiliations
- PMID: 17702962
- DOI: 10.1161/STROKEAHA.107.483008
Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats
Masanori Iwai et al. Stroke. 2007 Oct.
Abstract
Background and purpose: Erythropoietin (EPO) has been well characterized and shown to improve functional outcomes after ischemic injury, but EPO may also have unexplored effects on neurovascular remodeling and neuronal replacement in the neonatal ischemic brain. The current study investigates the effects of exogenous administration of EPO on revascularization and neurogenesis, 2 major events thought to contribute to neuronal replacement, in the neonatal brain after hypoxia/ischemia (H/I).
Methods: Seven-day-old rat pups were treated with recombinant human EPO or vehicle 20 minutes after H/I and again on postischemic days 2, 4, and 6. Rats were euthanized 7 or 28 days after H/I for evaluation of infarct volume, revascularization, neurogenesis, and neuronal replacement using bromodeoxyuridine incorporation, immunohistochemistry, and lectin labeling. Neurological function was assessed progressively for 28 days after H/I by gait testing, righting reflex and foot fault testing.
Results: We demonstrate that exogenous EPO-enhanced revascularization in the ischemic hemisphere correlated with decreased infarct volume and improved neurological outcomes after H/I. In addition to vascular effects, EPO increased both neurogenesis in the subventricular zone and migration of neuronal progenitors into the ischemic cortex and striatum. A significant number of newly synthesized cells in the ischemic boundary expressed neuronal nuclei after EPO treatment, indicating that exogenous EPO led to neuronal replacement.
Conclusions: Our data suggest that treatment with EPO contributes to neurovascular remodeling after H/I by promoting tissue protection, revascularization, and neurogenesis in neonatal H/I-injured brain, leading to improved neurobehavioral outcomes.
Similar articles
- Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury.
Iwai M, Stetler RA, Xing J, Hu X, Gao Y, Zhang W, Chen J, Cao G. Iwai M, et al. Stroke. 2010 May;41(5):1032-7. doi: 10.1161/STROKEAHA.109.570325. Epub 2010 Apr 1. Stroke. 2010. PMID: 20360553 Free PMC article. - Erythropoietin downregulates bax and DP5 proapoptotic gene expression in neonatal hypoxic-ischemic brain injury.
Kumral A, Genc S, Ozer E, Yilmaz O, Gokmen N, Koroglu TF, Duman N, Genc K, Ozkan H. Kumral A, et al. Biol Neonate. 2006;89(3):205-10. doi: 10.1159/000089951. Epub 2005 Nov 24. Biol Neonate. 2006. PMID: 16319448 - Recombinant human erythropoietin augments angiogenic responses in a neonatal rat model of cerebral unilateral hypoxia-ischemia.
Zhu L, Bai X, Wang S, Hu Y, Wang T, Qian L, Jiang L. Zhu L, et al. Neonatology. 2014;106(2):143-8. doi: 10.1159/000362262. Epub 2014 Jun 24. Neonatology. 2014. PMID: 24969821 - Erythropoietin for neonatal brain injury: opportunity and challenge.
Xiong T, Qu Y, Mu D, Ferriero D. Xiong T, et al. Int J Dev Neurosci. 2011 Oct;29(6):583-91. doi: 10.1016/j.ijdevneu.2010.12.007. Epub 2011 Jan 28. Int J Dev Neurosci. 2011. PMID: 21277366 Review. - Erythropoietin for infants with hypoxic-ischemic encephalopathy.
McPherson RJ, Juul SE. McPherson RJ, et al. Curr Opin Pediatr. 2010 Apr;22(2):139-45. doi: 10.1097/MOP.0b013e328336eb57. Curr Opin Pediatr. 2010. PMID: 20090525 Free PMC article. Review.
Cited by
- Neuronal nitric oxide synthase required for erythropoietin modulation of heart function in mice.
Lee J, Rogers HM, Springer DA, Noguchi CT. Lee J, et al. Front Physiol. 2024 Apr 2;15:1338476. doi: 10.3389/fphys.2024.1338476. eCollection 2024. Front Physiol. 2024. PMID: 38628440 Free PMC article. - New therapeutic hypothesis for infantile extrinsic hydrocephalus.
Kameda M, Kajimoto Y, Wanibuchi M. Kameda M, et al. Front Neurol. 2023 Sep 19;14:1215560. doi: 10.3389/fneur.2023.1215560. eCollection 2023. Front Neurol. 2023. PMID: 37794877 Free PMC article. No abstract available. - Evaluation of neurovascular coupling during neuroprotective therapies: A single site HEAL ancillary study.
Chalak LF, Kang S, Kota S, Liu H, Liu Y, Juul SE, Wu YW. Chalak LF, et al. Early Hum Dev. 2023 Aug;183:105815. doi: 10.1016/j.earlhumdev.2023.105815. Epub 2023 Jul 3. Early Hum Dev. 2023. PMID: 37419079 Free PMC article. - Beyond brain injury biomarkers: chemoattractants and circulating progenitor cells as biomarkers of endogenous rehabilitation effort in preterm neonates with encephalopathy.
Efstathiou N, Soubasi V, Koliakos G, Kantziou K, Kyriazis G, Slavakis A, Dermentzoglou V, Michalettou I, Drosou-Agakidou V. Efstathiou N, et al. Front Pediatr. 2023 May 24;11:1151787. doi: 10.3389/fped.2023.1151787. eCollection 2023. Front Pediatr. 2023. PMID: 37292373 Free PMC article. - Telomerase reverse transcriptase promotes angiogenesis in neonatal rats after hypoxic-ischemic brain damage.
Li J, Feng Y, Zhao J, Fang Z, Liu H. Li J, et al. PeerJ. 2022 Oct 21;10:e14220. doi: 10.7717/peerj.14220. eCollection 2022. PeerJ. 2022. PMID: 36299510 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials